KELLER WILLIAM R 4
4 · ALEXION PHARMACEUTICALS INC · Filed May 22, 2013
Insider Transaction Report
Form 4
KELLER WILLIAM R
Director
Transactions
- Exercise/Conversion
Option to Purchase Common Stock
2013-05-20−3,237→ 0 totalExercise: $85.75From: 2012-08-08Exp: 2022-05-08→ Common Stock, par value $.0001 per share (3,237 underlying) - Exercise/Conversion
Common Stock, par value $.0001 per share
2013-05-20$23.05/sh+3,747$86,368→ 16,023 total - Exercise/Conversion
Common Stock, par value $.0001 per share
2013-05-20$49.43/sh+2,786$137,712→ 18,809 total - Exercise/Conversion
Common Stock, par value $.0001 per share
2013-05-20$85.75/sh+3,237$277,573→ 22,046 total - Sale
Common Stock, par value $.0001 per share
2013-05-20$103.00/sh−9,770$1,006,310→ 12,276 total - Exercise/Conversion
Option to Purchase Common Stock
2013-05-20−3,747→ 0 totalExercise: $23.05From: 2010-03-01Exp: 2019-12-01→ Common Stock, par value $.0001 per share (3,747 underlying) - Exercise/Conversion
Option to Purchase Common Stock
2013-05-20−2,786→ 0 totalExercise: $49.43From: 2011-08-11Exp: 2021-05-11→ Common Stock, par value $.0001 per share (2,786 underlying)